Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1CNS 1

Conditions

Brain Neoplasms 4Sarcoma 3Neoplasms 3Recurrence 2Ovarian Neoplasms 2Neoplasm Metastasis 2Nasopharyngeal Carcinoma 2Medulloblastoma 2Glioblastoma 2Central Nervous System Neoplasms 2Breast Neoplasms 2Astrocytoma 2Urologic Neoplasms 1Thyroid Neoplasms 1Spinal Cord Neoplasms 1Solid Tumors 1Solid Tumor Malignancies 1Soft Tissue Neoplasms 1Pharyngeal Neoplasms 1Osteosarcoma 1Optic Nerve Glioma 1Neurofibromatosis 2 1Neuroectodermal Tumors, Primitive, Peripheral 1Neuroectodermal Tumors, Primitive 1Neuroectodermal Tumors 1Neuroblastoma 1Neoplasms, Mesothelial 1Myelodysplastic Syndromes 1Multiple Acyl Coenzyme A Dehydrogenase Deficiency 1Mouth Neoplasms 1

Interventions

Filgrastim 7Peripheral Blood Stem Cell Transplantation 4Melphalan 4Etoposide 4Carboplatin 4Busulfan 4Ifosfamide 3Granulocyte Colony-Stimulating Factor 3tanespimycin 2Thiotepa 2Temozolomide 2Mesna 2Docetaxel 2Cyclophosphamide 2trioctyl phosphine oxide 1temsirolimus 1sargramostim 1pegfilgrastim 1omburtamab I-131 1montanide ISA 51 1ixabepilone 1ganitumab 1entinostat 1cixutumumab 1amino-acid, glucose, and electrolyte solution 1alvocidib 1aldesleukin 1Valproic Acid 1Transplantation 1Topotecan 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 1 × Neuroectodermal Tumors, Primitive, Peripheral × Valproic Acid × Clear all
NCT01204450 2016-12-23

Temsirolimus and Valproic Acid in Treating Young Patients With Relapsed Neuroblastoma, Bone Sarcoma, or Soft Tissue Sarcoma

UNC Lineberger Comprehensive Cancer Center

Phase 1 Terminated
7 enrolled
CNSSarcoma

Neuroblastoma, Sarcoma, Osteosarcoma, Central Nervous System Neoplasms, Neuroectodermal Tumors, Primitive, Peripheral

Data powered by HemOnc (CC BY 4.0) Colophon âš¡